Octreotide Enhances Positive Calcium Balance in Duchenne Muscular Dystrophy

The trial was successful in reducing the rise in LDL cholesterol during perimenopause to postmenopause but could not completely eliminate the rise in LDL cholesterol. The trial was also successful in preventing the increase in weight from premenopause to perimenopause to postmenopause. The difference in LDL cholesterol between the assessment and intervention groups was most pronounced among postmenopausal women and occurred among hormone users and nonusers.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Octreotide Enhances Positive Calcium Balance in Duchenne Muscular Dystrophy

Cited by 3 publications

References 34 publications

Octreotide: Effective treatment for hyperparathyroidism? A prospective, randomized, controlled clinical trial

Octreotide: Effective treatment for hyperparathyroidism? A prospective, randomized, controlled clinical trial

Role of octreotide on release of intact 1–84 parathyroid hormone from human parathyroid cells

Women’s Healthy Lifestyle Project: A Randomized Clinical Trial

Contact Info

Product

Resources

About